Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Gastric Cancer
Published in: Gastric Cancer 2/2005

01-05-2005 | Special article

Molecular-pathological prognostic factors of gastric cancer: a review

Authors: Wataru Yasui, Naohide Oue, Phyu Phyu Aung, Shunji Matsumura, Mariko Shutoh, Hirofumi Nakayama

Published in: Gastric Cancer | Issue 2/2005

Login to get access
Metadata
Title
Molecular-pathological prognostic factors of gastric cancer: a review
Authors
Wataru Yasui
Naohide Oue
Phyu Phyu Aung
Shunji Matsumura
Mariko Shutoh
Hirofumi Nakayama
Publication date
01-05-2005
Publisher
Springer-Verlag
Published in
Gastric Cancer / Issue 2/2005
Print ISSN: 1436-3291
Electronic ISSN: 1436-3305
DOI
https://doi.org/10.1007/s10120-005-0320-0

Other articles of this Issue 2/2005

Gastric Cancer 2/2005 Go to the issue

Special article

Current status and future prospects of chemotherapy for metastatic gastric cancer: a review

Original article

Clinical significance of interleukin-6 (IL-6) in the spread of gastric cancer: role of IL-6 as a prognostic factor

Special article

Strategies for gastric cancer treatment in the twenty-first century: minimally invasive and tailored approaches integrating basic science and clinical medicine

Special article

Laparoscopic surgery for gastric cancer: preliminary experience

Special article

Gastric cancer: the dispute between East and West

Special article

Thirty-four-year experience of immunochemosurgery for gastric cancer in 14 033 cases
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits